Patent Assignment
Reel/Frame 053372/0377
Change of Name
Recorded: 2020-07-31
Pages: 42
Assignor
CELLERIX, S.A.U.
Executed: 2012-02-13
Assignee
TIGENIX, S.A.U.
MARCONI, 1, PARQUE TECNOLÓGICO DE MADRID, TRES CANTOS - MADRID, E-28760, SPAIN
Covered Property
(1)
Use of Adipose Tissue-Derived Stromal Stem Cells in Treating Fistula
Application:
16/722,872 →
Publication:
US 2020/0206274
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Conversion
Jul 31, 2020
From: CELLERIX, S.L.
To: CELLERIX, S.A.
Reel/Frame 053372/0292 →
Conversion
Jul 31, 2020
From: CELLERIX, S.A.
To: CELLERIX, S.A.U.
Reel/Frame 053372/0344 →
Assignment of Assignor's Interest
Jul 31, 2020
From: FERNÁNDEZ MIGUEL, MARÍA GEMA; GONZÁLEZ DE LA PEÑA, MANUEL ÁNGEL; GARCÍA CASTRO, ROSA ANA
To: CELLERIX, S.L.
Reel/Frame 053373/0839 →
Assignment of Assignor's Interest
Jul 31, 2020
From: GARCÍA ARRANZ, MARIANO; GARCÍA-OLMO, DAMIÁN
To: UNIVERSIDAD AUTÓNOMA DE MADRID
Reel/Frame 053373/0895 →
Assignment of Assignor's Interest
Jun 15, 2022
From: TIGENIX, S.A.U.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 060516/0532 →